The effect of docosahexaenoic acid on plasma catecholamine concentrations and glucose tolerance during long-lasting psychological stress: A double-blind placebo-controlled study
S. Sawazaki et al., The effect of docosahexaenoic acid on plasma catecholamine concentrations and glucose tolerance during long-lasting psychological stress: A double-blind placebo-controlled study, J NUTR SC V, 45(5), 1999, pp. 655-665
We previously found that docosahexaenoic acid (DHA) intake prevented aggres
sion from increasing at times of mental stress. In the present study, we in
vestigated whether DHA intake modified the plasma catecholamines and cortis
ol of medical students during a 9-wk period of final exams. We also investi
gated the effects of DHA intake on a 75 g oral glucose tolerance test (oGTT
S. Fourteen medical students participated in the present study. They were r
andomly allocated to either control or DHA group in a double-blind manner.
Subjects in the control group (4 males and 3 females) took 10 control capsu
les/d, each capsule containing 280 mg of mixed plant oil, and those in the
DHA group (4 males and 3 females) took 10 DHA capsules/d containing 1.5 g D
HA for 9 wk, during which subjects underwent more than 20 stressful final e
xams. At the start and end of the study, plasma catecholamines (epinephrine
, norepinephrine (NE) and dopamine) and cortisol were measured; a 75g oGTT
was also performed. There were no intra- or intergroup differences in plasm
a glucose concentrations. However, NE concentrations were significantly red
uced after DHA administration (-31 %, p < 0.03). The other catecholamines a
nd cortisol did not change significantly. The plasma ratio of epinephrine t
o NE increased in every DHA subject (+78%, p < 0.02), and intergroup differ
ences were significant (p < 0.03). We conclude that these effects of DHA ma
y be applied to people under long-lasting psychological stress to prevent s
tress-related diseases.